SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-123101
Filing Date
2020-11-09
Accepted
2020-11-09 16:37:22
Documents
15
Period of Report
2020-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2035367d1_8k.htm   iXBRL 8-K 31916
2 EXHIBIT 99.1 tm2035367d1_ex99-1.htm EX-99.1 175512
7 GRAPHIC image_001.jpg GRAPHIC 19865
  Complete submission text file 0001104659-20-123101.txt   479210

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fbio-20201109.xsd EX-101.SCH 3766
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fbio-20201109_def.xml EX-101.DEF 27399
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbio-20201109_lab.xml EX-101.LAB 37117
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbio-20201109_pre.xml EX-101.PRE 26024
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2035367d1_8k_htm.xml XML 5449
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35366 | Film No.: 201298277
SIC: 2834 Pharmaceutical Preparations